Skip to results
Modify your search
NARROW
1-20 of 36
Authors: Aida Karachi
Sort by
Journal Article
EXTH-07. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR MICROENVIRONMENT POST-SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
Lan Hoang-Minh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v225, https://doi.org/10.1093/neuonc/noad179.0861
Published: 10 November 2023
Journal Article
IMMU-20. MESSENGER RNA CHALLENGE RAPIDLY PREDICTS BRAIN TUMOR RESPONSIVENESS TO CHECKPOINT INHIBITORS
Paul Castillo and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v145–v146, https://doi.org/10.1093/neuonc/noad179.0552
Published: 10 November 2023
Journal Article
IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
James McGuiness and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i50, https://doi.org/10.1093/neuonc/noad073.193
Published: 12 June 2023
Journal Article
EXTH-38. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR IMMUNE MICROENVIRONMENT AFTER SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
Lan Hoang-Minh and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii217–vii218, https://doi.org/10.1093/neuonc/noac209.836
Published: 14 November 2022
Journal Article
EXTH-46. RNA LIPID PARTICLES INDUCE BI-DIRECTIONAL IMMUNITY AGAINST DIFFUSE MIDLINE GLIOMA
James McGuiness and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii219, https://doi.org/10.1093/neuonc/noac209.844
Published: 14 November 2022
Journal Article
CTIM-28. MULTILAMELLAR MRNA LIPID PARTICLES INDUCE IMMUNOLOGIC REPROGRAMMING IN CANINE AND HUMAN GLIOBLASTOMA PATIENTS
Hector Mendez-Gomez and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii66–vii67, https://doi.org/10.1093/neuonc/noac209.260
Published: 14 November 2022
Journal Article
SURG-01. DEVELOPMENT OF MURINE MODEL OF LASER INTERSTITIAL THERMOTHERAPY (LITT) FOR BRAIN TUMORS
Matthew Frain and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii251, https://doi.org/10.1093/neuonc/noac209.967
Published: 14 November 2022
Journal Article
IMMU-20. HYDROGEL-CXCL9 VACCINE RESULTS IN MRNA DELIVERY TO DENDRITIC CELLS AND POTENT ANTI-TUMOR RESPONSES IN GBM
Farhad Dastmalchi and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi96, https://doi.org/10.1093/neuonc/noab196.379
Published: 12 November 2021
Journal Article
TAMI-27. METABOLIC MANIPULATION OF T CELLS TO TREAT BRAIN TUMORS
Guimei Tian and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi203–vi204, https://doi.org/10.1093/neuonc/noab196.811
Published: 12 November 2021
Journal Article
CBIO-16. DOSE INTENSIFIED TEMOZOLOMIDE IMPROVES INFILTRATION OF CD70 CAR T CELLS INTO THE GBM TUMOR MICROENVIRONMENT
Aida Karachi and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi30, https://doi.org/10.1093/neuonc/noab196.116
Published: 12 November 2021
Journal Article
EXTH-22. NEOADJUVANT IMMUNOTHERAPY WITH ANTI-PD1 ALTERS THE TUMOR MICROENVIRONMENT POST SURGERY IN A MODEL OF RECURRENT GLIOBLASTOMA
Lan Hoang-Minh and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi168, https://doi.org/10.1093/neuonc/noab196.661
Published: 12 November 2021
Journal Article
IMMU-38. PRECLINICAL VALIDATION AND MANUFACTURE OF IL-8 RECEPTOR-MODIFIED CD70 CAR T CELLS FOR CLINICAL TRIAL
Linchun Jin and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii113, https://doi.org/10.1093/neuonc/noaa215.468
Published: 09 November 2020
Journal Article
IMMU-24. TEMOZOLOMIDE INDUCED IMMUNE DYSFUNCTION REQUIRES THE PRESENCE OF INTRACRANIAL TUMORS
Aida Karachi and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii109–ii110, https://doi.org/10.1093/neuonc/noaa215.454
Published: 09 November 2020
Journal Article
BIOM-36. THE UNIQUE METABOLOMICS BASED BIOMARKERS OF RESPONSE TO IMMUNOTHERAPY FOR GLIOBLASTOMA
Farhad Dastmalchi and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii9, https://doi.org/10.1093/neuonc/noaa215.035
Published: 09 November 2020
Journal Article
TAMI-19. METABOLIC INTERACTIONS BETWEEN TUMOR CELLS AND THE IMMUNE SYSTEM IN GBM: A POTENTIAL ACHILLES HEEL OF GBM FOR NOVEL THERAPEUTICS
Guimei Tian and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii217, https://doi.org/10.1093/neuonc/noaa215.908
Published: 09 November 2020
Journal Article
IMMU-22. EARLY RELEASE OF TYPE I INTERFERON DRIVES BRAIN CANCER IMMUNOGENICITY AND RESPONSE TO IMMUNOTHERAPY
Brandon Wummer and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii109, https://doi.org/10.1093/neuonc/noaa215.452
Published: 09 November 2020
Journal Article
EDITOR'S CHOICE
Adult immuno-oncology: using past failures to inform the future
Maryam Rahman and others
Neuro-Oncology, Volume 22, Issue 9, September 2020, Pages 1249–1261, https://doi.org/10.1093/neuonc/noaa116
Published: 11 May 2020
Journal Article
EXTH-15. INCREASING THE TRAFFICKING OF DENDRITIC CELLS VIA CXC CHEMOKINE SIGNALING PATHWAY LEADS TO IMPROVED ANTI-TUMOR EFFICACY OF DENDRITIC CELL VACCINES
Farhad Dastmalchi and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi85, https://doi.org/10.1093/neuonc/noz175.349
Published: 11 November 2019
Journal Article
IMMU-26. RADIATION AND TEMOZOLOMIDE UP-REGULATES CD70 EXPRESSION AND ENHANCES CAR T- CELL RECOGNITION IN GBM
Meng Na and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi124, https://doi.org/10.1093/neuonc/noz175.519
Published: 11 November 2019
Journal Article
TMIC-29. METABOLIC INTERACTIONS BETWEEN TREATMENT-RESISTANT SLOW-CYCLING CELLS AND THE IMMUNE SYSTEM IN HIGH-GRADE GLIOMA
Elias Sayour and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi253–vi254, https://doi.org/10.1093/neuonc/noz175.1063
Published: 11 November 2019
Advertisement
Advertisement